Phase 3 Readout~month

Phase 3 Topline: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotal

Name: Phase 3 Topline: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotal
Start: 2028-08-15

August 15, 2028

Company: Aura Biosciences, Inc. (AURA)
Indication: Uveal Melanoma; Ocular Melanoma; Choroidal Melanoma

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start Free Full Calendar

Phase 3 Topline: A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotal — AURA Phase 3 Readout | BioSniper